Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy

Clinical Transplantation

Volumn 27, Issue 3, 2013, Pages

  Cuellar Rodriguez, Jennifer ^a,e   Stephany, Brian ^b   Poggio, Emilio ^b   Mossad, Sherif B ^a   Goldfarb, David ^c   Lard, Michelle ^b   Askar, Medhat ^d   Fatica, Richard ^b   Srinivas, Titte ^b   Braun, William ^b   Shoskes, Daniel ^c   Flechner, Stuart ^c   Schmitt, Steven K ^a   Shrestha, Rabin ^a   Avery, Robin K ^a  

^a Medicine Institute   (United States)

^b Glickman Urologic and Kidney Institute   (United States)

^c Surgery Institute The Cleveland Clinic ^*  (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

BK virus; Leflunomide; Polyomavirus; Viral load; Viremia

Indexed keywords

CIDOFOVIR; CREATININE; IMMUNOGLOBULIN; LEFLUNOMIDE; QUINOLONE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE; VIRUS DNA;

ALLOGRAFT; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; BK VIRUS; BK VIRUS INFECTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTOPENIA; DIARRHEA; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT RECIPIENT; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LIVER FUNCTION TEST; NEUROPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SIDE EFFECT; TREATMENT RESPONSE; VIRUS LOAD; BLOOD; DRUG EFFECTS; FEMALE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIREMIA; VIROLOGY;

BK VIRUS; DNA, VIRAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA;

EID: 84878644069     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12110     Document Type: Article

References (21)

1. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005: 79: 1277.
2. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006: 69: 655.
3. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007: 2(Suppl 1): S36.
4. Randhawa P, Brennan DC. BK virus infection in transplant recipients: an overview and update. Am J Transplant 2006: 6: 2000.
5. Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005: 5: 582.
6. Ginevri F, Azzi A, Hirsch HH et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007: 7: 2727.
7. Sessa A, Esposito A, Giliberti A et al. BKV reactivation in renal transplant recipients: diagnostic and therapeutic strategy-case reports. Transplant Proc 2008: 40: 2055.
8. Trofe J, Hirsch HH, Ramos E. Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients. Transpl Infect Dis 2006: 8: 76.
9. Hirsch HH, Randhawa P. BK virus in solid organ transplant recipients. Am J Transplant 2009: 9(Suppl 4): S136.
10. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 2010: 10: 407.
11. Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008: 13: 569.
12. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009: 87: 621.
13. Womer KL, Guerra G, Dibadj K et al. Immunosuppression reduction for BK virus nephropathy: a case for caution. Transpl Infect Dis 2007: 9: 244.
14. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 2006a: 8: 95.
15. Josephson MA, Gillen D, Javaid B et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006b: 81: 704.
16. Williams JW, Javaid B, Kadambi PV et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005: 352: 1157.
17. Faguer S, Hirsch HH, Kamar N et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 2007: 20: 962.
18. Chong AS, Zeng H, Knight DA et al. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant 2006: 6: 69.
19. Williams JW, Mital D, Chong A et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002: 73: 358.
20. Bohl DL, Storch GA, Ryschkewitsch C et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005: 5: 2213.
21. Sener A, House AA, Jevnikar AM et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 2006: 81: 117.